
Netflix, Inc.
- Growing?
- Yes: revenue up 12% on a year earlier (quarter ended Sep 2026); earnings per share up 45% over the last four quarters.
- Expensive?
- Cheaper than usual: 18.1× trailing earnings; its five-year median is 42.8×. In line with the peer median of 19.2x (excludes 3 unprofitable peers).
- Analysts?
- 65% of 51 say buy; average 12-month target $84.76, 35% above today's price.
- Risky?
- Swingier than most large companies: its price swung 36% over the past year (the S&P 500's 14%), and it fell as much as 76% since Nov 2021.
Netflix, Inc. operates Netflix, a global subscription streaming service delivering on-demand TV series, films, and games, monetized primarily via monthly membership plans (including ad-supported and ad-free tiers) and supported by content licensing and production.
More about Netflix
Market Position
Netflix is one of the largest global streaming platforms by scale, differentiated by a broad original content slate, strong recommendation/personalization and product experience, and global distribution that supports local-language production and worldwide releases.
Key Segments
Netflix reports as a single operating segment and manages the business primarily on a consolidated basis, with key product lines including streaming content and mobile/TV games delivered through the Netflix app.
How has the stock done?
Over the past month NFLX fell 11.2%; the communication services ETF (XLC) fell 3.5% and the S&P 500 fell 2.7%. 1 Congress filing by portfolios that hold it fall in this period.
Over the past six months NFLX fell 28.5%; the communication services ETF (XLC) fell 7.2% and the S&P 500 rose 2.6%. 1 Congress filing by portfolios that hold it fall in this period.
Over the past year NFLX fell 45.8%; the communication services ETF (XLC) fell 5.3% and the S&P 500 rose 10.8%. 1 Congress filing by portfolios that hold it fall in this period.
Over five years NFLX fell 8.2%; the communication services ETF (XLC) rose 32.4% and the S&P 500 rose 62.0%. 1 Congress filing by portfolios that hold it fall in this period.
From Nov 17, 2021 to May 11, 2022, the deepest drop from a high since Nov 2021
How much the price swings in a year; the S&P 500's was 14%
When the S&P 500 moves 1%, the stock has moved about 0.2% the same way
Show the Congress filings
| Filed | Portfolio | NFLX in the filing | Latest trade in filing | NFLX share |
|---|---|---|---|---|
| Oct 22, 2026 | Cleo Fields | No NFLX trade in it | Oct 9, 2026 | 2.3% |
Show the earnings releases
| Released | Quarter | Revenue | EPS vs estimate | Stock, day after | 5 days after |
|---|---|---|---|---|---|
| Oct 20, 2026 | ended Sep 2026 | $12.9B (+12% vs a year earlier) | $0.87 vs $0.82 (beat) | −6.9% | −10.5% |
| Jul 16, 2026 | ended Jun 2026 | $12.6B (+13% vs a year earlier) | $0.80 vs $0.79 (beat) | −6.4% | −6.5% |
| Apr 16, 2026 | ended Mar 2026 | $12.2B (+16% vs a year earlier) | $1.23 vs $1.25 (missed) | −9.7% | −13.8% |
| Jan 20, 2026 | ended Dec 2025 | $12.1B (+18% vs a year earlier) | $0.56 vs $0.55 (beat) | −3.0% | −2.7% |
| Oct 21, 2025 | ended Sep 2025 | $11.5B (+17% vs a year earlier) | — | −9.9% | −11.0% |
| Jul 17, 2025 | ended Jun 2025 | $11.1B (+16% vs a year earlier) | — | −3.3% | −5.6% |
| Apr 17, 2025 | ended Mar 2025 | $10.5B (+13% vs a year earlier) | — | +2.7% | +14.5% |
| Jan 21, 2025 | ended Dec 2024 | $10.2B (+16% vs a year earlier) | — | +11.2% | +13.3% |
| Oct 17, 2024 | ended Sep 2024 | $9.8B (+15% vs a year earlier) | — | +8.8% | +7.5% |
| Jul 18, 2024 | ended Jun 2024 | $9.6B (+17% vs a year earlier) | — | −2.2% | −2.1% |
| Apr 18, 2024 | ended Mar 2024 | $9.4B (+15% vs a year earlier) | — | −9.6% | −8.0% |
| Jan 23, 2024 | ended Dec 2023 | $8.8B (+12% vs a year earlier) | — | +12.2% | +15.9% |
| Oct 18, 2023 | ended Sep 2023 | $8.5B (+8% vs a year earlier) | — | +12.9% | +15.6% |
| Jul 19, 2023 | ended Jun 2023 | $8.2B (+3% vs a year earlier) | — | −7.9% | −11.0% |
| Apr 18, 2023 | ended Mar 2023 | $8.2B (+4% vs a year earlier) | — | −2.9% | −3.1% |
| Jan 19, 2023 | ended Dec 2022 | $7.9B (+2% vs a year earlier) | — | +5.0% | +11.8% |
| Oct 18, 2022 | ended Sep 2022 | $7.9B (+6% vs a year earlier) | — | +11.1% | +18.7% |
| Jul 19, 2022 | ended Jun 2022 | $8.0B (+9% vs a year earlier) | — | +13.4% | +12.0% |
| Apr 19, 2022 | ended Mar 2022 | $7.9B (+10% vs a year earlier) | — | −33.1% | −41.3% |
| Jan 20, 2022 | ended Dec 2021 | $7.7B (+16% vs a year earlier) | — | −22.9% | −25.0% |
Change in closing price from the first day shown, or with Price the closing price itself. Prices: Yahoo Finance, to Nov 12, 2026. Dots on the line: a member of Congress whose Hunch portfolio holds NFLX filed a disclosure; its hover says what the disclosure reports of NFLX: each trade, bought or sold, with the amount range the member filed (the House asks for a range, not the amount), or in an annual report the range of the holding’s value, the ranges of its entries added up (“in all”) where the report lists NFLX more than once, in several accounts or share classes: a sum that bounds the value as the ranges do but is not a range the form offers. An annual report’s row has no latest trade. Filings: the Clerk of the House. Dashed lines: the days the company released earnings (its SEC 8-K filings); EPS estimates: Yahoo Finance. The stock's move after a release runs from the last close before its day to the close the day after (or five days after), so a release before the open counts like one after the close.
Is the business growing?
Revenue was $12.9B in the quarter ended Sep 2026, up 12% from a year earlier.
Show the data
| Quarter ended | Revenue | vs a year earlier |
|---|---|---|
| Dec 2022 | $7.9B | +2% |
| Mar 2023 | $8.2B | +4% |
| Jun 2023 | $8.2B | +3% |
| Sep 2023 | $8.5B | +8% |
| Dec 2023 | $8.8B | +12% |
| Mar 2024 | $9.4B | +15% |
| Jun 2024 | $9.6B | +17% |
| Sep 2024 | $9.8B | +15% |
| Dec 2024 | $10.2B | +16% |
| Mar 2025 | $10.5B | +13% |
| Jun 2025 | $11.1B | +16% |
| Sep 2025 | $11.5B | +17% |
| Dec 2025 | $12.1B | +18% |
| Mar 2026 | $12.2B | +16% |
| Jun 2026 | $12.6B | +13% |
| Sep 2026 | $12.9B | +12% |
Revenue went from $31.6B in FY22 to $45.2B in FY25; net income from $4.5B to $11.0B.
Show the data
| Fiscal year | Revenue | Net income |
|---|---|---|
| FY22 | $31.6B | $4.5B |
| FY23 | $33.7B | $5.4B |
| FY24 | $39.0B | $8.7B |
| FY25 | $45.2B | $11.0B |
A year earlier $0.59
Diluted, from SEC filings
The P/E of 18.1× over the 45% EPS growth of the last four quarters; near 1 or below is cheap for the growth
Quarters: Netflix, Inc.'s SEC filings, named by the month they end. Fiscal years: Netflix, Inc.'s annual reports to the SEC.
How it makes money
Of every $100 in revenue, $24.3 ends up as net income. Net margin rose from 14.2% to 24.3% over the past 3 years.
Show the data
| Quarter ended | Gross | Operating | Net |
|---|---|---|---|
| Dec 2022 | 31.2% | 7.0% | 0.7% |
| Mar 2023 | 41.1% | 21.0% | 16.0% |
| Jun 2023 | 42.9% | 22.3% | 18.2% |
| Sep 2023 | 42.3% | 22.4% | 19.6% |
| Dec 2023 | 39.9% | 16.9% | 10.6% |
| Mar 2024 | 46.9% | 28.1% | 24.9% |
| Jun 2024 | 45.9% | 27.2% | 22.5% |
| Sep 2024 | 47.9% | 29.6% | 24.1% |
| Dec 2024 | 43.7% | 22.2% | 18.2% |
| Mar 2025 | 50.1% | 31.7% | 27.4% |
| Jun 2025 | 51.9% | 34.1% | 28.2% |
| Sep 2025 | 46.4% | 28.2% | 22.1% |
| Dec 2025 | 45.9% | 24.5% | 20.1% |
| Mar 2026 | 51.9% | 32.3% | 43.1% |
| Jun 2026 | 51.9% | 33.4% | 27.1% |
| Sep 2026 | 52.8% | 34.6% | 28.5% |
Circled: Mar 2026 (net 43.1%, operating 32.3%). Net margin is usually about 5 points below operating margin; in that quarter something below operating income (a tax charge or benefit, a gain or loss on investments, a write-down) moved it, not the business itself.
+9.1 pts over 3 years
+11.7 pts over 3 years
+10.1 pts over 3 years
Each margin is that line of the income statement divided by revenue. Fiscal year: Netflix, Inc.'s annual reports to the SEC; quarters: SEC filings.
How much does it spend on building?
Netflix spent $933M on property and equipment in the four quarters to Sep 2026, 1.9% of its revenue, against 1.4% a year earlier. That is 8% of the cash its operations brought in.
Up 53.5% on the four quarters before
1.4% a year earlier
$12.3B over the same four quarters
Show the data
| Quarter ended | Capital spending | Revenue | Cash from operations | Share of revenue, four quarters |
|---|---|---|---|---|
| Dec 2023 | $82M | $8.8B | $1.7B | 1.0% |
| Mar 2024 | $76M | $9.4B | $2.2B | 1.0% |
| Jun 2024 | $78M | $9.6B | $1.3B | 0.9% |
| Sep 2024 | $127M | $9.8B | $2.3B | 1.0% |
| Dec 2024 | $159M | $10.2B | $1.5B | 1.1% |
| Mar 2025 | $128M | $10.5B | $2.8B | 1.2% |
| Jun 2025 | $156M | $11.1B | $2.4B | 1.4% |
| Sep 2025 | $165M | $11.5B | $2.8B | 1.4% |
| Dec 2025 | $239M | $12.1B | $2.1B | 1.5% |
| Mar 2026 | $196M | $12.2B | $5.3B | 1.6% |
| Jun 2026 | $219M | $12.6B | $1.7B | 1.7% |
| Sep 2026 | $279M | $12.9B | $3.2B | 1.9% |
From Netflix, Inc.'s SEC filings: payments for property and equipment by quarter (networks, data centers, buildings; software built for its own use where the company counts it in), the fourth quarter being the year minus nine months; the share is the four quarters' spending over their revenue.
How much goes into research?
Netflix spent $3.9B on research and development in the four quarters to Sep 2026, 7.8% of its revenue, against 7.6% a year earlier. Over the year its research spending rose 18.7% and its revenue rose 14.7%.
Up 18.7% on the four quarters before
7.6% a year earlier
Show the data
| Quarter ended | Research and development | Revenue | Share of revenue, four quarters |
|---|---|---|---|
| Dec 2023 | $673M | $8.8B | 7.9% |
| Mar 2024 | $702M | $9.4B | 7.7% |
| Jun 2024 | $711M | $9.6B | 7.6% |
| Sep 2024 | $735M | $9.8B | 7.5% |
| Dec 2024 | $777M | $10.2B | 7.5% |
| Mar 2025 | $823M | $10.5B | 7.6% |
| Jun 2025 | $825M | $11.1B | 7.6% |
| Sep 2025 | $854M | $11.5B | 7.6% |
| Dec 2025 | $890M | $12.1B | 7.5% |
| Mar 2026 | $960M | $12.2B | 7.5% |
| Jun 2026 | $1.0B | $12.6B | 7.7% |
| Sep 2026 | $1.0B | $12.9B | 7.8% |
From Netflix, Inc.'s SEC filings: research and development expense by quarter, the fourth being the year minus nine months; its share is the four quarters' expense over their revenue. Some companies count the research they buy, through licences and acquisitions, in this line, so it jumps in the quarter they pay; others report that on a line of its own, not shown here.
Customers and suppliers
In its latest annual report Netflix buys from Amazon.
Their suppliers
Suppliers
Named in other companies’ filings
Show the filing's words
| Company | Role | In the filing's words |
|---|---|---|
| Amazon | supplier | “Despite these measures and technologies we, our payment processing services or other third-party services we use such as AWS, could experience an unauthorized intrusion into our members’ information.” |
| Comcast (10-K filed Feb 3, 2026) | distribution deal with it | “Our video packages range from a basic to full linear service and typically include free-to-air networks, a variety of other linear television networks including premium, sports and news networks, and certain direct-to-consumer streaming services (“DTC streaming services”) such as Peacock, Disney+ and Netflix.” |
Only the companies Netflix names in its 10-K filed Jan 23, 2026 (SEC). Named in other companies' filings: those whose own latest annual report or an 8-K since names Netflix. The supply chain joins the latest annual reports of the companies on it and the 8-Ks they filed since: a link shows when either side's report names the other, so it grows as more reports are read. Hover a name for the filing's own words.
Is it expensive?
P/E of 18.1x, in line with the peer median of 19.2x, with earnings still growing.
In line with the peer median of 19.2x (excludes 3 unprofitable peers).
Show the data
| Company | P/E (trailing) |
|---|---|
| DIS · The Walt Disney Company | 24.4× |
| NFLX · Netflix, Inc. | 18.1× |
| FOXA · Fox Corporation | 14× |
| WBD · Warner Bros. Discovery Inc | Loss |
| LYV · Live Nation Entertainment, Inc. | Loss |
| SKYD · Skydance Corporation | Loss |
At 18.1× trailing earnings NFLX is below most of its five-year range; the five-year median is 42.8×.
Show the data
| Date | Trailing P/E |
|---|---|
| Nov 8, 2021 | 58.7× |
| Feb 8, 2022 | 35.9× |
| May 10, 2022 | 16.1× |
| Aug 10, 2022 | 21.7× |
| Nov 8, 2022 | 23.6× |
| Feb 9, 2023 | 36.4× |
| May 11, 2023 | 37.1× |
| Aug 11, 2023 | 44.9× |
| Nov 9, 2023 | 43.4× |
| Feb 12, 2024 | 46.5× |
| May 13, 2024 | 42.8× |
| Aug 13, 2024 | 40.5× |
| Nov 11, 2024 | 45.6× |
| Feb 13, 2025 | 52.7× |
| May 15, 2025 | 55.8× |
| Aug 15, 2025 | 52.9× |
| Nov 13, 2025 | 48.2× |
| Feb 17, 2026 | 30.4× |
| May 18, 2026 | 28.9× |
| Aug 18, 2026 | 24.5× |
| Nov 12, 2026 | 18.1× |
Closing price over diluted earnings per share of the last four reported quarters, as known on each day (a quarter counts 35 days after it ends). From SEC filings; earnings per share adjusted for splits.
What analysts expect
The average analyst price target is $84.76, 35% above the current price; 65% of 51 analysts rate it a buy; earnings beat estimates in 3 of the last 4 quarters.
Buy or Strong Buy: 33 analysts (65%). Sell or Strong Sell: 2.
Over the past year the average of the analysts' latest price targets went from $141.25 to $84.28 (−40%), while NFLX went from $115.42 to $62.69 (−46%). In the past three months targets were raised 3 times and cut 23 times. 5 upgrades and 8 downgrades over the year; the latest: Wolfe Research moved it to Peer Perform from Outperform on Oct 22, 2026.
Show every change
| Date | Firm | Change | Rating | Target |
|---|---|---|---|---|
| Oct 22, 2026 | Wolfe Research | Downgrade | Peer Perform, was Outperform | — |
| Oct 22, 2026 | Argus Research | Target cut | Buy | $95.00, was $120.00 |
| Oct 22, 2026 | Pivotal Research | Target cut | Hold | $65.00, was $70.00 |
| Oct 21, 2026 | UBS | Target cut | Buy | $100.00, was $115.00 |
| Oct 21, 2026 | Citigroup | Target cut | Buy | $85.00, was $100.00 |
| Oct 21, 2026 | Oppenheimer | Target cut | Outperform | $80.00, was $85.00 |
| Oct 21, 2026 | Morgan Stanley | Target cut | Overweight | $77.00, was $80.00 |
| Oct 21, 2026 | JP Morgan | Target cut | Overweight | $81.00, was $85.00 |
| Oct 21, 2026 | TD Cowen | Target kept | Buy | $100.00 |
| Oct 21, 2026 | Piper Sandler | Target cut | Overweight | $78.00, was $85.00 |
| Oct 21, 2026 | Evercore ISI Group | Target cut | Outperform | $90.00, was $110.00 |
| Oct 21, 2026 | Barclays | Target cut | Equal-Weight | $65.00, was $70.00 |
| Oct 21, 2026 | Guggenheim | Target cut | Buy | $78.00, was $80.00 |
| Oct 21, 2026 | Citizens | Rating kept | Market Perform | — |
| Oct 21, 2026 | Wedbush | Target cut | Outperform | $80.00, was $90.00 |
| Oct 21, 2026 | Bernstein | Target cut | Outperform | $80.00, was $95.00 |
| Oct 21, 2026 | Rosenblatt | Target cut | Neutral | $71.00, was $75.00 |
| Oct 21, 2026 | Needham | Downgrade | Hold, was Buy | — |
| Oct 21, 2026 | B of A Securities | Target cut | Buy | $90.00, was $105.00 |
| Oct 16, 2026 | BMO Capital | Target cut | Outperform | $125.00, was $135.00 |
| Oct 16, 2026 | Wedbush | Target cut | Outperform | $90.00, was $105.00 |
| Oct 16, 2026 | Rosenblatt | Target kept | Neutral | $75.00 |
| Oct 13, 2026 | Keybanc | Target cut | Overweight | $85.00, was $92.00 |
| Oct 8, 2026 | Morgan Stanley | Target cut | Overweight | $80.00, was $83.00 |
| Oct 7, 2026 | Barclays | Target cut | Equal-Weight | $70.00, was $80.00 |
| Oct 5, 2026 | TD Cowen | Target kept | Buy | $100.00 |
| Oct 1, 2026 | Guggenheim | Target raised | Buy | $80.00, was $75.00 |
| Sep 29, 2026 | Deutsche Bank | Upgrade | Buy, was Hold | $95.00, was $100.00 |
| Sep 22, 2026 | HSBC | Downgrade | Hold, was Buy | $76.00, was $96.00 |
| Sep 18, 2026 | Wells Fargo | Downgrade | Underweight, was Equal-Weight | $57.00, was $80.00 |
| Sep 14, 2026 | Evercore ISI Group | Target raised | Outperform | $110.00, was $100.00 |
| Aug 25, 2026 | Wolfe Research | Target raised | Outperform | $95.00, was $84.00 |
| Jul 22, 2026 | Baird | Target cut | Outperform | $90.00, was $120.00 |
| Jul 17, 2026 | Goldman Sachs | Target cut | Buy | $94.00, was $110.00 |
| Jul 17, 2026 | Piper Sandler | Target cut | Overweight | $85.00, was $115.00 |
| Jul 17, 2026 | JP Morgan | Target cut | Overweight | $85.00, was $118.00 |
| Jul 17, 2026 | Morgan Stanley | Target cut | Overweight | $83.00, was $90.00 |
| Jul 17, 2026 | KGI Securities | Downgrade | Neutral, was Outperform | $75.00 |
| Jul 17, 2026 | Oppenheimer | Target cut | Outperform | $85.00, was $100.00 |
| Jul 17, 2026 | Rosenblatt | Target cut | Neutral | $75.00, was $95.00 |
| Jul 17, 2026 | Wells Fargo | Target cut | Equal-Weight | $80.00, was $105.00 |
| Jul 17, 2026 | Evercore ISI Group | Target cut | Outperform | $100.00, was $115.00 |
| Jul 17, 2026 | UBS | Target cut | Buy | $115.00, was $130.00 |
| Jul 17, 2026 | Wedbush | Target cut | Outperform | $105.00, was $118.00 |
| Jul 17, 2026 | Guggenheim | Target cut | Buy | $75.00, was $120.00 |
| Jul 17, 2026 | Barclays | Target cut | Equal-Weight | $80.00, was $85.00 |
| Jul 17, 2026 | TD Cowen | Target cut | Buy | $100.00, was $112.00 |
| Jul 17, 2026 | Bernstein | Target cut | Outperform | $95.00, was $100.00 |
| Jul 17, 2026 | Pivotal Research | Target cut | Hold | $70.00, was $96.00 |
| Jul 15, 2026 | Guggenheim | Target kept | Buy | $120.00 |
| Jul 14, 2026 | Morgan Stanley | Target cut | Overweight | $90.00, was $115.00 |
| Jul 14, 2026 | Rosenblatt | Target kept | Neutral | $95.00 |
| Jul 14, 2026 | Barclays | Target cut | Equal-Weight | $85.00, was $110.00 |
| Jul 13, 2026 | Oppenheimer | Target cut | Outperform | $100.00, was $120.00 |
| Jul 13, 2026 | Keybanc | Target cut | Overweight | $92.00, was $115.00 |
| Jul 9, 2026 | Citigroup | Target cut | Buy | $100.00, was $115.00 |
| Jul 8, 2026 | Bernstein | Target cut | Outperform | $100.00, was $110.00 |
| May 18, 2026 | B of A Securities | Target kept | Buy | $125.00 |
| May 15, 2026 | Guggenheim | Target kept | Buy | $120.00 |
| Apr 17, 2026 | Piper Sandler | Target raised | Overweight | $115.00, was $103.00 |
| Apr 17, 2026 | Oppenheimer | Target cut | Outperform | $120.00, was $135.00 |
| Apr 17, 2026 | Barclays | Target cut | Equal-Weight | $110.00, was $115.00 |
| Apr 17, 2026 | Citizens | Rating kept | Market Perform | — |
| Apr 17, 2026 | Keybanc | Target kept | Overweight | $115.00 |
| Apr 17, 2026 | Wedbush | Target kept | Outperform | $118.00 |
| Apr 17, 2026 | Rosenblatt | Target cut | Neutral | $95.00, was $96.00 |
| Apr 17, 2026 | Guggenheim | Target cut | Buy | $120.00, was $130.00 |
| Apr 15, 2026 | Citizens | Rating kept | Market Perform | — |
| Apr 14, 2026 | Guggenheim | Target kept | Buy | $130.00 |
| Apr 14, 2026 | Keybanc | Target raised | Overweight | $115.00, was $108.00 |
| Apr 13, 2026 | Wedbush | Target raised | Outperform | $118.00, was $115.00 |
| Apr 6, 2026 | Rosenblatt | Target raised | Neutral | $96.00, was $95.00 |
| Apr 6, 2026 | Goldman Sachs | Upgrade | Buy, was Neutral | $120.00, was $100.00 |
| Mar 30, 2026 | Citizens | Began coverage | Market Perform | — |
| Mar 27, 2026 | Oppenheimer | Target raised | Outperform | $135.00, was $125.00 |
| Mar 6, 2026 | CFRA | Upgrade | Buy, was Hold | $115.00 |
| Mar 6, 2026 | B of A Securities | Target cut | Buy | $125.00, was $149.00 |
| Mar 2, 2026 | JP Morgan | Upgrade | Overweight, was Neutral | $120.00, was $124.00 |
| Feb 27, 2026 | Rosenblatt | Target raised | Neutral | $95.00, was $94.00 |
| Feb 20, 2026 | Wedbush | Target kept | Outperform | $115.00 |
| Jan 27, 2026 | Freedom Broker | Upgrade | Buy, was Hold | $104.00, was $107.00 |
| Jan 22, 2026 | Argus Research | Target cut | Buy | $110.00, was $141.00 |
| Jan 21, 2026 | Oppenheimer | Target cut | Outperform | $125.00, was $145.00 |
| Jan 21, 2026 | Deutsche Bank | Target raised | Hold | $98.00, was $95.00 |
| Jan 21, 2026 | TD Cowen | Target cut | Buy | $112.00, was $115.00 |
| Jan 21, 2026 | Piper Sandler | Target cut | Overweight | $103.00, was $140.00 |
| Jan 21, 2026 | Wolfe Research | Target cut | Outperform | $95.00, was $121.00 |
| Jan 21, 2026 | UBS | Target cut | Buy | $130.00, was $150.00 |
| Jan 21, 2026 | Wedbush | Target kept | Outperform | $115.00 |
| Jan 21, 2026 | Keybanc | Target cut | Overweight | $108.00, was $110.00 |
| Jan 21, 2026 | Canaccord Genuity | Target cut | Buy | $125.00, was $152.50 |
| Jan 21, 2026 | BMO Capital | Target cut | Outperform | $135.00, was $143.00 |
| Jan 21, 2026 | Morgan Stanley | Target cut | Overweight | $110.00, was $120.00 |
| Jan 21, 2026 | Guggenheim | Target cut | Buy | $130.00, was $145.00 |
| Jan 21, 2026 | Rosenblatt | Target cut | Neutral | $94.00, was $105.00 |
| Jan 21, 2026 | Needham | Target cut | Buy | $120.00, was $150.00 |
| Jan 21, 2026 | Goldman Sachs | Target cut | Neutral | $100.00, was $112.00 |
| Jan 21, 2026 | Pivotal Research | Target cut | Hold | $95.00, was $105.00 |
| Jan 16, 2026 | Keybanc | Target cut | Overweight | $110.00, was $139.00 |
| Jan 16, 2026 | Rosenblatt | Target kept | Neutral | $105.00 |
| Jan 15, 2026 | Wedbush | Target cut | Outperform | $115.00, was $140.00 |
| Jan 13, 2026 | TD Cowen | Target cut | Buy | $115.00, was $142.00 |
| Jan 12, 2026 | HSBC | Began coverage | Buy | $107.00 |
| Jan 5, 2026 | CFRA | Downgrade | Hold, was Buy | $100.00 |
| Dec 11, 2025 | Jefferies | Target cut | Buy | $134.00, was $150.00 |
| Dec 9, 2025 | Needham | Target kept | Buy | $150.00 |
| Dec 8, 2025 | Canaccord Genuity | Target kept | Buy | $152.50 |
| Dec 8, 2025 | Pivotal Research | Downgrade | Hold, was Buy | $105.00, was $160.00 |
| Dec 8, 2025 | Rosenblatt | Downgrade | Neutral, was Buy | $105.00, was $152.00 |
| Nov 28, 2025 | Rosenblatt | Target cut | Buy | $152.00, was $153.00 |
| Nov 18, 2025 | Barclays | Target kept | Equal-Weight | $110.00 |
| Nov 18, 2025 | JP Morgan | Target cut | Neutral | $124.00, was $127.50 |
Show the data
| Quarter | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec ’25 | $0.55 | $0.56 | +1.8% |
| Mar ’26 | $1.25 | $1.23 | −1.6% |
| Jun ’26 | $0.79 | $0.80 | +1.3% |
| Sep ’26 | $0.82 | $0.87 | +6.1% |
The day after each of these reports the stock moved −3.0% (Dec 2025, beat); −9.7% (Mar 2026, missed); −6.4% (Jun 2026, beat); −6.9% (Sep 2026, beat).
For the quarter ending Dec 2026 (Netflix reports on Jan 19, 2027), analysts expect adjusted earnings of $0.68 a share, 21% more than the $0.56 of a year earlier, and revenue of $13.4B, up 12% on a year earlier. For the fiscal year ending Dec 2027, they expect adjusted earnings of $3.77 a share, 5% more than the year before's estimate of $3.58, and revenue of $56.6B, up 11% on the year before's estimate.
Adjusted. Dec 2025: $0.56; range $0.66 to $0.71; 32 analysts
Dec 2025: $12.1B; range $13.4B to $13.5B; 35 analysts
Adjusted. The year to Dec 2026: $3.58 expected; range $3.56 to $4.00; 44 analysts
The year to Dec 2026: $51.1B expected; range $55.5B to $57.5B; 45 analysts
Show the data
| Period | Figure | Expected | Low to high | Analysts | A year earlier | Change |
|---|---|---|---|---|---|---|
| Quarter ending Dec 2026, results Jan 19, 2027 | EPS (adjusted) | $0.68 | $0.66 to $0.71 | 32 | $0.56 (Dec 2025) | +21% |
| Quarter ending Dec 2026, results Jan 19, 2027 | Revenue | $13.4B | $13.4B to $13.5B | 35 | $12.1B (Dec 2025) | +12% |
| Quarter ending Mar 2027 | EPS (adjusted) | $0.92 | $0.88 to $0.97 | 20 | $1.23 (Mar 2026) | −25% |
| Quarter ending Mar 2027 | Revenue | $13.6B | $13.4B to $13.8B | 21 | $12.2B (Mar 2026) | +11% |
| Year ending Dec 2026 | EPS (adjusted) | $3.58 | $3.51 to $3.64 | 37 | — | — |
| Year ending Dec 2026 | Revenue | $51.1B | $51.0B to $51.2B | 41 | $45.2B (year to Dec 2025) | +13% |
| Year ending Dec 2027 | EPS (adjusted) | $3.77 | $3.56 to $4.00 | 44 | $3.58 (expected, year to Dec 2026) | +5% |
| Year ending Dec 2027 | Revenue | $56.6B | $55.5B to $57.5B | 45 | $51.1B (expected, year to Dec 2026) | +11% |
Targets, ratings and earnings estimates: Yahoo Finance. Rating and target changes: Yahoo Finance's list of upgrades and downgrades. The average target on each day is the average of every listed firm's latest target set in the 180 days before it, so it counts fewer analysts than the average target above, and the band is the middle half of those targets (a quarter of the firms are above it, a quarter below); a target set before a stock split is divided by the split. Expected figures: the average of the analysts' estimates (Yahoo Finance). Their EPS is adjusted, as analysts estimate it, so it is set against the adjusted EPS Yahoo reports for the same quarters, not the GAAP EPS of the growth and valuation sections; revenue against the SEC filings. No change is given against a quarter whose reported EPS was more than 50% off its own estimate (often a one-off gain or charge), nor against a year that counts one. Each estimate is pinned to its fiscal period by the report date or the period's end, and one that cannot be is left out.
Where the cash goes
Generated $11.4B in free cash flow over the year and returned more than it generated: $12.9B went back to shareholders (dividends plus buybacks), so $1.5B came from cash on hand or borrowing.
Show the data
| Line | Amount |
|---|---|
| Op. cash flow | $12.3B |
| Capex | −$900M |
| Free cash flow | $11.4B |
| Dividends | — |
| Buybacks | −$12.9B |
| Cash retained | −$1.5B |
For every $100 of market cap, the company generates about $4.4 in free cash flow a year.
No dividend today; cash goes to growth and share buybacks.
Dividends plus buybacks over the last four quarters: for every $100 of market cap, about $5.0 went back to shareholders.
Show the data
| Quarter ended | Free cash flow | Dividends | Buybacks |
|---|---|---|---|
| Dec 2023 | $1.6B | — | $2.5B |
| Mar 2024 | $2.1B | — | $2.0B |
| Jun 2024 | $1.2B | — | $1.6B |
| Sep 2024 | $2.2B | — | $1.7B |
| Dec 2024 | $1.4B | — | $964M |
| Mar 2025 | $2.7B | — | $3.5B |
| Jun 2025 | $2.3B | — | $1.7B |
| Sep 2025 | $2.7B | — | $1.9B |
| Dec 2025 | $1.9B | — | $2.1B |
| Mar 2026 | $5.1B | — | $1.3B |
| Jun 2026 | $1.5B | — | $4.7B |
| Sep 2026 | $2.9B | — | $4.8B |
Free cash flow: operating cash flow minus capital spending on property, plant and equipment, from SEC filings, for the last 4 quarters and by quarter.
Financial health
Current ratio 1.2, short-term debt is manageable; debt-to-equity 0.5, debt is moderate.
Assets that can be turned into cash soon are 1.2x what is owed within a year. 1.5 or higher is comfortable; below 1 needs watching.
For every $1 of shareholder funds, there is $0.5 of debt. The higher the number, the more pressure when the economy weakens.
Cash and short-term investments of $9.1B against debt of $14.5B.
Latest fiscal year balance sheet. Source: Yahoo Finance.
Who holds it
3 portfolios Hunch tracks hold NFLX: 1 member of Congress and 2 funds. It is 17.4% of Fundsmith's portfolio (3.7% as filed).
FundFundsmithNFLX is 17% of this portfolio+31.7%
FundPershing Square Capital ManagementNFLX is 13% of this portfolio+90.1%
CongressCleo FieldsNFLX is 2% of this portfolio+32.2%
NFLX's weight in each portfolio is its target weight in the copy Hunch follows: the stocks of the latest filing that the app can trade, their weights scaled up to add to 100%. “As filed” is its weight in the filing itself: a fund’s latest 13F, or a member of Congress’s holdings from the last annual report and the trades disclosed since, each at the low end of its range. Returns are backtests based on public filings, not actual trading results. Photo credits
What did the funds Hunch tracks do?
Of the 83 funds whose 13F filings Hunch reads, 27 held NFLX at the end of their latest quarter (for most, Q2 2026). Over that quarter 9 added shares, 12 cut, 3 bought new, 4 sold all and 3 held the same. The largest of them is Norges Bank, 57.95M shares worth $4.1B at Jun 30, 2026, 6.4% fewer than at Dec 31, 2025.
3 of them new holders
4 of them sold all
Show every fund
| Fund | Quarter | Shares | Value | Change in shares | Change | Filed |
|---|---|---|---|---|---|---|
| Norges Bank | Q2 2026 vs Q4 2025 | 57.95M | $4.1B | −3.94M | −6.4% | Aug 12, 2026 |
| Fisher Asset Management | Q3 2026 | 20.30M | $1.4B | −116,928 | −0.6% | Nov 6, 2026 |
| Pershing Square Capital Management | Q2 2026 | 13.08M | $934M | +13.08M | New | Aug 14, 2026 |
| Swiss National Bank | Q3 2026 | 11.39M | $792M | −487,400 | −4.1% | Nov 12, 2026 |
| Harris Associates L P | Q2 2026 | 11.01M | $786M | +1.16M | +12% | Aug 14, 2026 |
| National Pension Service | Q3 2026 | 9.79M | $681M | +72,609 | +0.7% | Nov 12, 2026 |
| Baillie Gifford & | Q3 2026 | 8.81M | $613M | −7.36M | −46% | Nov 9, 2026 |
| Canada Pension Plan Investment Board | Q2 2026 | 8.46M | $604M | −27,443 | −0.3% | Aug 14, 2026 |
| Fundsmith | Q2 2026 | 6.99M | $499M | +6.99M | New | Aug 14, 2026 |
| Newlands Management Operations | Q2 2026 | 6.71M | $479M | 0 | 0.0% | Aug 14, 2026 |
| Gardner Russo & Quinn | Q3 2026 | 5.57M | $388M | −138,022 | −2.4% | Nov 12, 2026 |
| Coatue Management | Q2 2026 | 4.71M | $336M | −2.18M | −32% | Aug 14, 2026 |
| Mirae Asset Global Investments | Q3 2026 | 3.78M | $263M | +155,013 | +4.3% | Nov 3, 2026 |
| Tiger Global Management | Q2 2026 | 0 | — | −2.44M | Sold all | Aug 14, 2026 |
| Korea Investment | Q2 2026 | 3.05M | $218M | −586,985 | −16% | Aug 12, 2026 |
| Temasek Holdings (Private) | Q3 2026 | 2.95M | $205M | +424,204 | +17% | Oct 28, 2026 |
| Tudor Investment Corp Et Al | Q2 2026 | 2.67M | $191M | +2.47M | +1237% | Aug 14, 2026 |
| Harvard Management | Q2 2026 | 1.10M | $78.8M | +1.10M | New | Aug 14, 2026 |
| Nomura Holdings | Q2 2026 | 897,463 | $64.1M | +544,920 | +155% | Aug 14, 2026 |
| Renaissance Technologies | Q3 2026 | 901,768 | $62.7M | −5.89M | −87% | Nov 12, 2026 |
| Nan Shan Life Insurance | Q2 2026 | 665,142 | $47.5M | −145,028 | −18% | Aug 14, 2026 |
| Skye Global Management | Q2 2026 | 382,000 | $27.3M | +20,000 | +5.5% | Aug 14, 2026 |
| Jia Investment Alliance | Q3 2026 | 317,700 | $22.1M | 0 | 0.0% | Oct 6, 2026 |
| ARK Investment Management | Q2 2026 | 224,871 | $16.1M | +7,450 | +3.4% | Aug 14, 2026 |
| Whale Rock Capital Management | Q2 2026 | 0 | — | −131,960 | Sold all | Aug 14, 2026 |
| Stony Point Capital | Q2 2026 | 0 | — | −122,547 | Sold all | Aug 13, 2026 |
| Bridgewater Associates | Q2 2026 | 0 | — | −77,611 | Sold all | Aug 14, 2026 |
| Polen Capital Management | Q2 2026 | 68,139 | $4.9M | −15,146 | −18% | Aug 4, 2026 |
| Markel Group | Q3 2026 | 67,500 | $4.7M | +27,500 | +69% | Oct 30, 2026 |
| Soros Fund Management | Q2 2026 | 46,451 | $3.3M | −1,424 | −3.0% | Aug 14, 2026 |
| Ruane, Cunniff & Goldfarb | Q2 2026 | 8,091 | $578K | 0 | 0.0% | Aug 14, 2026 |
From the 13F filings of the 83 funds Hunch tracks, not of every institution: each fund's shares of NFLX at its latest quarter end against the quarter before, as filed (long positions only, options left out), the quarter before put on the latest quarter's share count across a split. A fund files 45 days after its quarter ends, so some have a newer quarter than others. Value is at the quarter end. Norges Bank filed its 13F for Q1 2026 confidentially, with no holdings made public, so its row compares Q2 2026 with Q4 2025.
Are insiders buying or selling?
Officers and directors sold $320M of NFLX on the open market in the 12 months to Nov 12, 2026; none bought. 94% of the sales were made under 10b5-1 plans, set up in advance. The largest was Reed Hastings (Director), who sold $264M in 21 sales.
62 sales
0 purchases
Share of the sales' value
Show every trade
| Date | Insider | Role | Trade | Shares | Price | Value | Filed |
|---|---|---|---|---|---|---|---|
| Nov 9, 2026 | Gregory K Peters | Co-CEO; director | Sale | 27,312 | $63.62 | $1.7M | Nov 10, 2026 |
| Nov 4, 2026 | Spencer Adam Neumann | Chief Financial Officer | Sale | 9,253 | $66.15 | $612K | Nov 5, 2026 |
| Nov 4, 2026 | Theodore A Sarandos | Co-CEO; director | Sale | 27,312 | $66.20 | $1.8M | Nov 5, 2026 |
| Nov 4, 2026 | David A Hyman | Chief Legal Officer | Sale | 5,727 | $64.55 | $370K | Nov 4, 2026 |
| Oct 26, 2026 | Bradford L Smith | Director | Sale (10b5-1 plan) | 11,980 | $63.55 | $761K | Oct 27, 2026 |
| Oct 26, 2026 | Bradford L Smith | Director | Sale (10b5-1 plan) | 1,800 | $64.61 | $116K | Oct 27, 2026 |
| Oct 26, 2026 | Bradford L Smith | Director | Sale (10b5-1 plan) | 4,200 | $65.14 | $274K | Oct 27, 2026 |
| Sep 10, 2026 | Richard N Barton | Director | Sale (10b5-1 plan) | 720 | $75.27 | $54K | Sep 10, 2026 |
| Sep 9, 2026 | Richard N Barton | Director | Sale (10b5-1 plan) | 720 | $76.26 | $55K | Sep 10, 2026 |
| Sep 8, 2026 | Richard N Barton | Director | Sale (10b5-1 plan) | 720 | $77.60 | $56K | Sep 9, 2026 |
| Aug 10, 2026 | Spencer Adam Neumann | Chief Financial Officer | Sale | 9,248 | $75.79 | $701K | Aug 10, 2026 |
| Aug 6, 2026 | Gregory K Peters | Co-CEO; director | Sale | 27,312 | $73.54 | $2.0M | Aug 6, 2026 |
| Aug 5, 2026 | Richard N Barton | Director | Sale (10b5-1 plan) | 2,160 | $75.10 | $162K | Aug 6, 2026 |
| Aug 4, 2026 | Theodore A Sarandos | Co-CEO; director | Sale | 27,312 | $73.35 | $2.0M | Aug 4, 2026 |
| Aug 4, 2026 | David A Hyman | Chief Legal Officer | Sale | 5,723 | $72.85 | $417K | Aug 4, 2026 |
| Aug 3, 2026 | Theodore A Sarandos | Co-CEO; director | Sale (10b5-1 plan) | 81,891 | $72.90 | $6.0M | Aug 4, 2026 |
| Aug 3, 2026 | Theodore A Sarandos | Co-CEO; director | Sale (10b5-1 plan) | 23,959 | $73.48 | $1.8M | Aug 4, 2026 |
| Jun 17, 2026 | Bradford L Smith | Director | Sale (10b5-1 plan) | 22,190 | $77.21 | $1.7M | Jun 18, 2026 |
| Jun 17, 2026 | Bradford L Smith | Director | Sale (10b5-1 plan) | 13,800 | $78.01 | $1.1M | Jun 18, 2026 |
| Jun 1, 2026 | Reed Hastings | Director | Sale (10b5-1 plan) | 332,917 | $85.85 | $28.6M | Jun 2, 2026 |
| Jun 1, 2026 | Reed Hastings | Director | Sale (10b5-1 plan) | 53,783 | $86.73 | $4.7M | Jun 2, 2026 |
| May 7, 2026 | Spencer Adam Neumann | Chief Financial Officer | Sale | 9,253 | $88.95 | $823K | May 7, 2026 |
| May 7, 2026 | Gregory K Peters | Co-CEO; director | Sale | 27,312 | $88.69 | $2.4M | May 7, 2026 |
| May 5, 2026 | David A Hyman | Chief Legal Officer | Sale | 5,722 | $88.08 | $504K | May 5, 2026 |
| May 5, 2026 | Theodore A Sarandos | Co-CEO; director | Sale | 13,017 | $87.96 | $1.1M | May 5, 2026 |
| May 5, 2026 | Theodore A Sarandos | Co-CEO; director | Sale | 7,256 | $87.97 | $638K | May 5, 2026 |
| May 5, 2026 | Theodore A Sarandos | Co-CEO; director | Sale | 7,039 | $87.98 | $619K | May 5, 2026 |
| May 1, 2026 | Reed Hastings | Director | Sale (10b5-1 plan) | 188,425 | $92.28 | $17.4M | May 4, 2026 |
| May 1, 2026 | Reed Hastings | Director | Sale (10b5-1 plan) | 105,791 | $93.54 | $9.9M | May 4, 2026 |
| May 1, 2026 | Reed Hastings | Director | Sale (10b5-1 plan) | 113,334 | $94.17 | $10.7M | May 4, 2026 |
| Apr 2, 2026 | Spencer Adam Neumann | Chief Financial Officer | Sale (10b5-1 plan) | 28,630 | $98.00 | $2.8M | Apr 3, 2026 |
| Apr 1, 2026 | Reed Hastings | Director | Sale (10b5-1 plan) | 152,047 | $95.02 | $14.4M | Apr 2, 2026 |
| Apr 1, 2026 | Reed Hastings | Director | Sale (10b5-1 plan) | 247,923 | $95.68 | $23.7M | Apr 2, 2026 |
| Apr 1, 2026 | Reed Hastings | Director | Sale (10b5-1 plan) | 20,580 | $96.66 | $2.0M | Apr 2, 2026 |
| Mar 2, 2026 | Reed Hastings | Director | Sale (10b5-1 plan) | 54,681 | $96.06 | $5.3M | Mar 3, 2026 |
| Mar 2, 2026 | Reed Hastings | Director | Sale (10b5-1 plan) | 227,680 | $96.92 | $22.1M | Mar 3, 2026 |
| Mar 2, 2026 | Reed Hastings | Director | Sale (10b5-1 plan) | 128,189 | $97.59 | $12.5M | Mar 3, 2026 |
| Mar 2, 2026 | Spencer Adam Neumann | Chief Financial Officer | Sale (10b5-1 plan) | 28,630 | $97.00 | $2.8M | Mar 3, 2026 |
| Feb 27, 2026 | Spencer Adam Neumann | Chief Financial Officer | Sale (10b5-1 plan) | 28,630 | $95.00 | $2.7M | Mar 2, 2026 |
| Feb 27, 2026 | Spencer Adam Neumann | Chief Financial Officer | Sale (10b5-1 plan) | 28,630 | $96.00 | $2.7M | Mar 2, 2026 |
| Feb 10, 2026 | Cletus R Willems | Chief Global Affairs Officer | Sale | 3,136 | $82.67 | $259K | Feb 11, 2026 |
| Feb 10, 2026 | Gregory K Peters | Co-CEO; director | Sale | 14,719 | $82.74 | $1.2M | Feb 11, 2026 |
| Feb 10, 2026 | Gregory K Peters | Co-CEO; director | Sale | 11,283 | $83.76 | $945K | Feb 11, 2026 |
| Feb 10, 2026 | Gregory K Peters | Co-CEO; director | Sale | 1,310 | $84.40 | $111K | Feb 11, 2026 |
| Feb 9, 2026 | David A Hyman | Chief Legal Officer | Sale | 5,727 | $81.06 | $464K | Feb 11, 2026 |
| Feb 6, 2026 | Spencer Adam Neumann | Chief Financial Officer | Sale | 9,248 | $81.27 | $752K | Feb 9, 2026 |
| Feb 2, 2026 | Reed Hastings | Director | Sale (10b5-1 plan) | 247,756 | $83.22 | $20.6M | Feb 3, 2026 |
| Feb 2, 2026 | Reed Hastings | Director | Sale (10b5-1 plan) | 104,594 | $84.09 | $8.8M | Feb 3, 2026 |
| Feb 2, 2026 | Reed Hastings | Director | Sale (10b5-1 plan) | 38,620 | $84.96 | $3.3M | Feb 3, 2026 |
| Jan 29, 2026 | Gregory K Peters | Co-CEO; director | Sale (10b5-1 plan) | 98,221 | $82.87 | $8.1M | Jan 30, 2026 |
| Jan 29, 2026 | Gregory K Peters | Co-CEO; director | Sale (10b5-1 plan) | 7,560 | $83.75 | $633K | Jan 30, 2026 |
| Jan 16, 2026 | David A Hyman | Chief Legal Officer | Sale (10b5-1 plan) | 23,439 | $88.11 | $2.1M | Jan 20, 2026 |
| Jan 15, 2026 | Bradford L Smith | Director | Sale (10b5-1 plan) | 11,306 | $88.27 | $998K | Jan 16, 2026 |
| Jan 15, 2026 | Bradford L Smith | Director | Sale (10b5-1 plan) | 20,454 | $89.18 | $1.8M | Jan 16, 2026 |
| Jan 15, 2026 | Bradford L Smith | Director | Sale (10b5-1 plan) | 30 | $89.86 | $2,696 | Jan 16, 2026 |
| Jan 2, 2026 | Reed Hastings | Director | Sale (10b5-1 plan) | 263,768 | $91.18 | $24.1M | Jan 5, 2026 |
| Jan 2, 2026 | Reed Hastings | Director | Sale (10b5-1 plan) | 146,324 | $92.32 | $13.5M | Jan 5, 2026 |
| Jan 2, 2026 | Reed Hastings | Director | Sale (10b5-1 plan) | 6,290 | $93.22 | $586K | Jan 5, 2026 |
| Jan 2, 2026 | Reed Hastings | Director | Sale (10b5-1 plan) | 9,908 | $94.00 | $931K | Jan 5, 2026 |
| Dec 1, 2025 | Reed Hastings | Director | Sale (10b5-1 plan) | 36,903 | $106.85 | $3.9M | Dec 2, 2025 |
| Dec 1, 2025 | Reed Hastings | Director | Sale (10b5-1 plan) | 140,595 | $108.20 | $15.2M | Dec 2, 2025 |
| Dec 1, 2025 | Reed Hastings | Director | Sale (10b5-1 plan) | 197,972 | $108.89 | $21.6M | Dec 2, 2025 |
From the Form 4s filed with the SEC about Netflix, Inc. (187 in the 12 months): purchases (code P) and sales (code S) on the open market by its officers and directors, at the price each filing gives (often an average of the day's trades). A sale is a 10b5-1 sale when its filing says it was made under such a plan, set up in advance. Not counted: 164 other transactions (grants, option exercises, shares withheld for tax and gifts).